GEODE CAPITAL MANAGEMENT, LLC - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is and the CUSIP is 49720K200. A total of 13 filers reported holding KINTARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$56,421
-0.3%
13,923
-0.8%
0.00%
Q2 2023$56,565
+9.5%
14,0360.0%0.00%
Q1 2023$51,652
+53149.5%
14,036
-0.7%
0.00%
Q4 2022$9714,1340.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Nantahala Capital Management 11,901$81,9980.01%
Lindbrook Capital, LLC 2,135$14,7100.00%
VANGUARD GROUP INC 14,831$102,1860.00%
UBS Group AG 1,404$9,6740.00%
OSAIC HOLDINGS, INC. 981$7,0000.00%
BANK OF AMERICA CORP /DE/ 1$70.00%
WELLS FARGO & COMPANY/MN 11$760.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,134$970.00%
STATE STREET CORP 21,442$147,7360.00%
View complete list of KINTARA THERAPEUTICS INC shareholders